Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001193125-26-037996

General Counsel sold 1,118 shares at $0.98 ($1,091)

  • General Counsel acquired 2,687 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

DENYES NANCY · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-03 Exercise or conversion : show line 1 in the form +2,687 34,242 D
2026-02-04 Sale : show line 2 in the form −1,118 $0.98 $1,091 33,124 D
Open-market sales · 1,118 sh · avg $0.98 · $1,091

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-03 Exercise or conversion : show line 3 in the form Restricted Stock Unit −2,687 0 D
Loading xslF345X05/ownership.xml…